Pancreatic beta-cell function and type 2 diabetes risk: Quantify the causal effect using a Mendelian randomization approach based on meta-analyses

Human Molecular Genetics

Volumn 21, Issue 22, 2012, Pages 5010-5018

  Song, Yiqing ^a,b   Yeung, Edwina ^c   Liu, Aiyi ^c   Vanderweele, Tyler J ^d   Chen, Liwei ^e   Lu, Chen ^f   Liu, Chunling ^g   Schisterman, Enrique F ^c   Ning, Yi ^h   Zhang, Cuilin ^c  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f BOSTON UNIVERSITY   (United States)

^g HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^h VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; TRANSCRIPTION FACTOR 7 LIKE 2;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; GENETIC ASSOCIATION; HOMEOSTASIS; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MENDELIAN RANDOMIZATION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ALLELES; DIABETES MELLITUS, TYPE 2; GENOTYPE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION GROUPS; RISK; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84868143292     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds339     Document Type: Article

References (38)

1. Dupuis, J., Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., Jackson, A.U., Wheeler, E., Glazer, N.L., Bouatia-Naji, N., Gloyn, A.L. et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet., 42, 105-116.
2. Ingelsson, E., Langenberg, C., Hivert, M.F., Prokopenko, I., Lyssenko, V., Dupuis, J., Magi, R., Sharp, S., Jackson, A.U., Assimes, T.L. et al. (2010) Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes, 59, 1266-1275.
3. Saxena, R., Hivert, M.F., Langenberg, C., Tanaka, T., Pankow, J.S., Vollenweider, P., Lyssenko, V., Bouatia-Naji, N., Dupuis, J., Jackson, A.U. et al. (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat. Genet., 42, 142-148.
4. Voight, B.F., Scott, L.J., Steinthorsdottir, V., Morris, A.P., Dina, C., Welch, R.P., Zeggini, E., Huth, C., Aulchenko, Y.S., Thorleifsson, G. et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet., 42, 579-589.
5. Ahlqvist, E., Ahluwalia, T.S. and Groop, L. (2011) Genetics of type 2 diabetes. Clin. Chem., 57, 241-254.
6. Bonnefond, A., Froguel, P. and Vaxillaire, M. (2010) The emerging genetics of type 2 diabetes. Trends Mol. Med., 16, 407-416.
7. Greenland, S. and Robins, J.M. (1986) Identifiability, exchangeability, and epidemiological confounding. Int. J. Epidemiol., 15, 413-419.
8. Lawlor, D.A., Harbord, R.M., Sterne, J.A., Timpson, N. and Davey Smith, G. (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med., 27, 1133-1163.
9. Smith, G.D. and Ebrahim, S. (2004) Mendelian randomization: prospects, potentials, and limitations. Int. J. Epidemiol., 33, 30-42.
10. Smith, G.D., Timpson, N. and Ebrahim, S. (2008) Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization. Ann. Med., 40, 524-541.
11. Grant, S.F., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A. et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet., 38, 320-323.
12. Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S. et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 445, 881-885.
13. Zeggini, E., Scott, L.J., Saxena, R., Voight, B.F., Marchini, J.L., Hu, T., de Bakker, P.I., Abecasis, G.R., Almgren, P., Andersen, G. et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet., 40, 638-645.
14. Smith, U. (2007) TCF7L2 and type 2 diabetes-we WNT to know. Diabetologia, 50, 5-7.
15. van de Bunt, M. and Gloyn, A.L. (2010) From genetic association to molecular mechanism. Curr. Diab. Rep., 10, 452-466.
16. Weedon, M.N. (2007) The importance of TCF7L2. Diabet. Med., 24, 1062-1066.
17. Shu, L., Matveyenko, A.V., Kerr-Conte, J., Cho, J.H., McIntosh, C.H. and Maedler, K. (2009) Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum. Mol. Genet., 18, 2388-2399.
18. Villareal, D.T., Robertson, H., Bell, G.I., Patterson, B.W., Tran, H., Wice, B. and Polonsky, K.S. (2010) TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes, 59, 479-485.
19. Shu, L., Sauter, N.S., Schulthess, F.T., Matveyenko, A.V., Oberholzer, J. and Maedler, K. (2008) Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes, 57, 645-653.
20. Gaulton, K.J., Nammo, T., Pasquali, L., Simon, J.M., Giresi, P.G., Fogarty, M.P., Panhuis, T.M., Mieczkowski, P., Secchi, A., Bosco, D. et al. (2010) A map of open chromatin in human pancreatic islets. Nat. Genet., 42, 255-259.
21. Hansson, O., Zhou, Y., Renstrom, E. and Osmark, P. (2010) Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes. Curr. Diab. Rep., 10, 444-451.
22. Bergman, R.N., Ader, M., Huecking, K. and Van Citters, G. (2002) Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes, 51(Suppl. 1), S212-S220.
23. Lyssenko, V., Lupi, R., Marchetti, P., Del Guerra, S., Orho-Melander, M., Almgren, P., Sjogren, M., Ling, C., Eriksson, K.F., Lethagen, A.L. et al. (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J. Clin. Invest., 117, 2155-2163.
24. Kahn, S.E., Zraika, S., Utzschneider, K.M. and Hull, R.L. (2009) The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia, 52, 1003-1012.
25. Maedler, K. (2008) Beta cells in type 2 diabetes - a crucial contribution to pathogenesis. Diabetes Obes. Metab., 10, 408-420.
26. Meier, J.J. (2009) Linking the genetics of type 2 diabetes with low birth weight: a role for prenatal islet maldevelopment? Diabetes, 58, 1255-1256.
27. DerSimonian, R. and Laird, N.M. (1986) Meta-analysis in clinical trials. Control Clin. Trials, 7, 177-188.
28. Cochran, W.G. (1954) The combination of estimates from different experiments. Biometrics, 10, 101-129.
29. Laird, N.M. and Mosteller, F. (1990) Some statistical methods for combining experimental results. Int. J. Technol. Assess. Health Care, 6, 5-30.
30. Whitehead, A. and Whitehead, J. (1991) A general parametric approach to the meta-analysis of randomized clinical trials. Stat. Med., 10, 1665-1677.
31. Hedges, L.V. and Pigott, T.D. (2001) The power of statistical tests in meta-analysis. Psychol. Methods, 6, 203-217.
32. Higgins, J., Thompson, S., Deeks, J. and Altman, D. (2002) Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J. Health Serv. Res. Policy, 7, 51-61.
33. Sutton, A.J., Abrams, K.R., Jones, D.R., Sheldon, T.A. and Song, F. (1998) Systematic reviews of trials and other studies. Health Technol. Assess., 2, 1-276.
34. Begg, C.B. and Mazumdar, M. (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-1101.
35. Egger, M., Davey Smith, G., Schneider, M. and Minder, C. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-634.
36. Tong, Y., Lin, Y., Zhang, Y., Yang, J., Liu, H. and Zhang, B. (2009) Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med. Genet., 10, 15.
37. Thompson, J.R., Minelli, C., Abrams, K.R., Tobin, M.D. and Riley, R.D. (2005) Meta-analysis of genetic studies using Mendelian randomization- a multivariate approach. Stat. Med., 24, 2241-2254.
38. Bowden, J. and Vansteelandt, S. (2011) Mendelian randomization analysis of case-control data using structural mean models. Stat. Med., 30, 678-694.